<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jeong M</submitter><funding>National Research Foundation of Korea</funding><pagination>1734</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9865349</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(2)</volume><pubmed_abstract>Rheumatoid arthritis (RA) is an inflammatory disease marked by a massive proliferation of synovial cells in the joints. In this study, we investigated the pro-apoptotic effects of docosahexaenoic acid (DHA) in human fibroblast-like synovial cells from RA patients (RA-FLS). An in vitro study using MH7A cells showed that DHA treatment induced caspase-8-dependent apoptosis in a dose-dependent manner and reduced the TNF-α-mediated induction of MMP-9 and IL-1β. DHA also induced the phosphorylation of eIF2α, the expression of the ER stress markers ATF4 and C/EBP homologous protein (CHOP), and death receptor 5 (DR5). The knockdown of CHOP or DR5 increased cell viability and reduced apoptosis in DHA-treated cells. Furthermore, the knockdown of CHOP reduced DHA-mediated DR5 expression, while the overexpression of CHOP increased DR5 expression. We also found that DHA treatment induced the accumulation of reactive oxygen species (ROS), and pretreatment with the anti-oxidant Tiron effectively abrogated not only the expression of CHOP and DR5, but also DHA-induced apoptosis. Under this condition, cell viability was increased, while PARP-1 cleavage and caspase-8 activation were reduced. All the findings were reproduced in human primary synovial cells obtained from RA patients. These results suggest that the DHA-mediated induction of ROS and CHOP induced apoptosis through the upregulation of DR5 in RA-FLSs, and that CHOP could be used as a therapy for RA.</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>DHA Induces Cell Death through the Production of ROS and the Upregulation of CHOP in Fibroblast-like Synovial Cells from Human Rheumatoid Arthritis Patients.</pubmed_title><pmcid>PMC9865349</pmcid><funding_grant_id>2022R1F1A1074572</funding_grant_id><funding_grant_id>2017M3A9G7072745</funding_grant_id><funding_grant_id>2017R1D1A1B03031743</funding_grant_id><pubmed_authors>Shin JI</pubmed_authors><pubmed_authors>Jeon YJ</pubmed_authors><pubmed_authors>Cho J</pubmed_authors><pubmed_authors>Lee K</pubmed_authors><pubmed_authors>Kim JH</pubmed_authors><pubmed_authors>Youn J</pubmed_authors><pubmed_authors>Jeong M</pubmed_authors></additional><is_claimable>false</is_claimable><name>DHA Induces Cell Death through the Production of ROS and the Upregulation of CHOP in Fibroblast-like Synovial Cells from Human Rheumatoid Arthritis Patients.</name><description>Rheumatoid arthritis (RA) is an inflammatory disease marked by a massive proliferation of synovial cells in the joints. In this study, we investigated the pro-apoptotic effects of docosahexaenoic acid (DHA) in human fibroblast-like synovial cells from RA patients (RA-FLS). An in vitro study using MH7A cells showed that DHA treatment induced caspase-8-dependent apoptosis in a dose-dependent manner and reduced the TNF-α-mediated induction of MMP-9 and IL-1β. DHA also induced the phosphorylation of eIF2α, the expression of the ER stress markers ATF4 and C/EBP homologous protein (CHOP), and death receptor 5 (DR5). The knockdown of CHOP or DR5 increased cell viability and reduced apoptosis in DHA-treated cells. Furthermore, the knockdown of CHOP reduced DHA-mediated DR5 expression, while the overexpression of CHOP increased DR5 expression. We also found that DHA treatment induced the accumulation of reactive oxygen species (ROS), and pretreatment with the anti-oxidant Tiron effectively abrogated not only the expression of CHOP and DR5, but also DHA-induced apoptosis. Under this condition, cell viability was increased, while PARP-1 cleavage and caspase-8 activation were reduced. All the findings were reproduced in human primary synovial cells obtained from RA patients. These results suggest that the DHA-mediated induction of ROS and CHOP induced apoptosis through the upregulation of DR5 in RA-FLSs, and that CHOP could be used as a therapy for RA.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2024-11-12T12:42:18.161Z</modification><creation>2024-11-12T12:42:18.161Z</creation></dates><accession>S-EPMC9865349</accession><cross_references><pubmed>36675245</pubmed><doi>10.3390/ijms24021734</doi></cross_references></HashMap>